Marcella Occelli

1.3k total citations
29 papers, 691 citations indexed

About

Marcella Occelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Marcella Occelli has authored 29 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Marcella Occelli's work include Cancer Treatment and Pharmacology (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Breast Cancer Treatment Studies (5 papers). Marcella Occelli is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Breast Cancer Treatment Studies (5 papers). Marcella Occelli collaborates with scholars based in Italy, United Kingdom and United States. Marcella Occelli's co-authors include Marco Merlano, Ornella Garrone, Ida Colantonio, Elena Fea, Milena Gasco, Gianmauro Numico, Cristina Granetto, Nicola Silvestris, Mauro Feola and Alberto Biggi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Marcella Occelli

29 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcella Occelli Italy 15 353 226 176 141 109 29 691
Leila A. Kutteh United States 14 634 1.8× 135 0.6× 117 0.7× 154 1.1× 117 1.1× 23 995
Bradley R. Corr United States 14 246 0.7× 92 0.4× 85 0.5× 154 1.1× 97 0.9× 64 699
Reinhilde Weytjens Belgium 8 337 1.0× 51 0.2× 161 0.9× 254 1.8× 123 1.1× 18 719
A. Vignoli Italy 5 136 0.4× 84 0.4× 99 0.6× 79 0.6× 158 1.4× 7 499
Elrasheid A. H. Kheirelseid Ireland 15 221 0.6× 58 0.3× 232 1.3× 287 2.0× 101 0.9× 27 916
Meral Günaldı Türkiye 17 280 0.8× 59 0.3× 109 0.6× 171 1.2× 25 0.2× 56 639
Laurence Venat‐Bouvet France 14 366 1.0× 29 0.1× 138 0.8× 96 0.7× 49 0.4× 40 647
Laura Attademo Italy 13 225 0.6× 71 0.3× 60 0.3× 172 1.2× 111 1.0× 21 560
E. Cohen United States 16 189 0.5× 65 0.3× 323 1.8× 195 1.4× 28 0.3× 43 1.1k
Annachiara Mitrugno United States 14 328 0.9× 76 0.3× 103 0.6× 184 1.3× 112 1.0× 18 688

Countries citing papers authored by Marcella Occelli

Since Specialization
Citations

This map shows the geographic impact of Marcella Occelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcella Occelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcella Occelli more than expected).

Fields of papers citing papers by Marcella Occelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcella Occelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcella Occelli. The network helps show where Marcella Occelli may publish in the future.

Co-authorship network of co-authors of Marcella Occelli

This figure shows the co-authorship network connecting the top 25 collaborators of Marcella Occelli. A scholar is included among the top collaborators of Marcella Occelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcella Occelli. Marcella Occelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muscaritoli, Maurizio, Alessandra Modena, Paolo Marchetti, et al.. (2023). The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study. Cancers. 15(12). 3206–3206. 9 indexed citations
2.
Numico, Gianmauro, Elena Fea, Ida Colantonio, et al.. (2023). Patients with cancer and hospital admissions: disease trajectory and strategic choices. BMJ Supportive & Palliative Care. 14(e2). e1721–e1724. 2 indexed citations
3.
Guida, Michele, Nicola Bartolomeo, Davide Quaresmini, et al.. (2022). Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. Journal of Translational Medicine. 20(1). 159–159. 19 indexed citations
4.
Guida, Michele, Nicola Bartolomeo, Pietro Quaglino, et al.. (2021). No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study. Cancers. 13(3). 475–475. 19 indexed citations
5.
Guida, Michele, Sabino Strippoli, Milena Maule, et al.. (2021). Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study. ESMO Open. 6(2). 100064–100064. 35 indexed citations
6.
Garrone, Ornella, Nerina Denaro, Fiorella Ruatta, et al.. (2020). Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy. Tumori Journal. 106(5). 427–431. 1 indexed citations
7.
Fea, Elena, Ida Colantonio, Nerina Denaro, et al.. (2016). Metronomic oral cyclophosphamide (CTX) in patients (pts) with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. 27. iv38–iv38. 2 indexed citations
8.
Numico, Gianmauro, Marcella Occelli, Marco Sicuro, et al.. (2016). Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion. Medicine. 95(15). e3273–e3273. 20 indexed citations
9.
Merlano, Marco, Marcella Occelli, & Ornella Garrone. (2016). Immune-related response criteria: light and shadows. ESMO Open. 1(4). e000082–e000082. 4 indexed citations
10.
Numico, Gianmauro, Marcella Occelli, Elvio Russi, et al.. (2011). Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score. Supportive Care in Cancer. 19(11). 1823–1830. 16 indexed citations
11.
Feola, Mauro, Ornella Garrone, Marcella Occelli, et al.. (2009). Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. International Journal of Cardiology. 148(2). 194–198. 120 indexed citations
12.
Smith, Paul J., Linda Nicholson, Nelofer Syed, et al.. (2007). Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (IGFBP)-Related Protein 1 and the Related IGFBPL1 in Inhibiting Breast Cancer Phenotypes. Clinical Cancer Research. 13(14). 4061–4068. 32 indexed citations
13.
Numico, Gianmauro, Elvio Russi, Ida Colantonio, et al.. (2006). Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: A pharmacology-guided schedule. International Journal of Radiation Oncology*Biology*Physics. 66(3). 731–737. 15 indexed citations
14.
Bertelli, Gianfilippo, Giuseppe Arena, Ornella Garrone, et al.. (2005). Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients. Cancer Chemotherapy and Pharmacology. 57(1). 46–51. 17 indexed citations
15.
Bertelli, Gianfilippo, Ornella Garrone, Marcella Occelli, et al.. (2005). Maintenance Hormone Therapy with Letrozole after First-Line Chemotherapy for Advanced Breast Cancer. Oncology. 68(4-6). 364–370. 17 indexed citations
16.
Numico, Gianmauro, Ornella Garrone, Nicola Silvestris, et al.. (2005). Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer. 103(5). 994–999. 166 indexed citations
17.
Bertelli, Gianfilippo, Ornella Garrone, Marco Merlano, et al.. (2005). Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer. Oncology. 69(6). 471–477. 68 indexed citations
18.
Garrone, Ornella, et al.. (2004). A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer. Anti-Cancer Drugs. 15(1). 23–27. 5 indexed citations
19.
Garrone, Ornella, et al.. (2004). Endometrial effects of tamoxifen (T) and exemestane (E) in early breast cancer patients (EBCP). A randomized phase III trial. Journal of Clinical Oncology. 22(14_suppl). 819–819. 7 indexed citations
20.
Rosso, R., Lucia Del Mastro, Antonio Durando, et al.. (2001). Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer a multicenter phase II study. 69(3). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leila A. Kutteh Breakdown of academic impact, for papers by Bradley R. Corr Breakdown of academic impact, for papers by Reinhilde Weytjens Breakdown of academic impact, for papers by A. Vignoli Breakdown of academic impact, for papers by Elrasheid A. H. Kheirelseid Breakdown of academic impact, for papers by Meral Günaldı Breakdown of academic impact, for papers by Laurence Venat‐Bouvet Breakdown of academic impact, for papers by Laura Attademo Breakdown of academic impact, for papers by E. Cohen Breakdown of academic impact, for papers by Annachiara Mitrugno
Rankless by CCL
2026